Send to

Choose Destination
See comment in PubMed Commons below
Pathol Biol (Paris). 2008 Jun;56(4):178-83. doi: 10.1016/j.patbio.2007.12.008. Epub 2008 Mar 5.

[Place of cancer among the risk factors in venous thromboembolism].

[Article in French]

Author information

  • 1EA 3878, groupe d'étude de la thrombose de Bretagne occidentale, département de médecine interne et de pneumologie, CHU Cavale Blanche, boulevard Tanguy-Prigent, 29609 Brest cedex, France.


There is a strong association between cancer and venous thromboembolism (VTE). Cancer patients have a seven-fold higher risk of developing VTE as compared with noncancer patients. In the year following the diagnosis of cancer, 1.6% of patients will develop a VTE event. VTE is one of the main cause of death in cancer patients, accounting for about 15% of deaths. On the other hand, cancer patients represent 15 to 20% of all VTE cases. Beyond classical risk factors for VTE, specific risk factors are associated with VTE in cancer patients: tumor site, stage, histological type, treatment, duration of the disease. VTE occurrence is associated with a poorer outcome in cancer patients: a reduced survival is observed in cancer patients with VTE as compared to non-VTE cancer patients. This impact of VTE on prognosis varies according to cancer characteristics. Conversely, evolution of VTE is different in cancer patients, with a higher short-term risk of mortality and a higher risk of recurrences, including on anticoagulant treatment, also modulated by cancer characteristics.

[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center